23:28 , Jun 7, 2018 |  BC Innovations  |  Translation in Brief

New Therapeutic Targets and Biomarkers: May 2018

New Therapeutic Targets and Biomarkers: May 2018 Select top therapeutic targets and biomarkers covered by BioCentury or added to the BCIQ database during May 2018. Therapeutic targets are defined as any protein, gene or other...
18:47 , May 30, 2018 |  BC Innovations  |  Distillery Therapeutics

Cancer

INDICATION: Colorectal cancer Patient sample, cell culture and mouse studies suggest promoting expression of the miR-371-373 cluster encoding miR-371, miR-372 and miR-373 or inhibiting the TGFβ-RII/ID1 axis could help treat colorectal cancer. In colorectal cancer...
08:00 , Nov 18, 2010 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Liver cancer MicroRNA-100 (miR-100); miRNA-let7a-2 (MIRLET7a2; LET-7a2); miR-371; miR-373 Studies in primary tumors suggest that a signature of four miRNAs could help guide treatment for...
07:00 , Mar 20, 2008 |  BC Innovations  |  Markers

Micro Management

In the past four years, at least two biotechs have released tests that use mRNA-based gene signatures to predict the likelihood of breast cancer recurrence. Now, research is emerging that suggests microRNAs could also have...
08:00 , Jan 31, 2008 |  BC Innovations  |  Distillery Therapeutics

This Week in Therapeutics

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Metastatic cancer miR-373; miR-520c; CD44 In vitro and in vivo studies suggest that miR-373 and miR-520c could be used as targets...